Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy, Power & Infrastructure
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
News & Insights
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Log In
Log In
Client Account Access
Fixed Income Client Portal
Merchant Banking Investor Access
Research Access
Read more
about Milestone-24-02-29
$30.0 Million
Image
Milestone Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
Read more
about NeedhamBank-2023-12-28
$410.0 Million
Image
The Needham Bank
Initial Public Offering
Sole Marketing Agent
Read more
about Ocular-2023-12-15
$115.1 Million
Image
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Keros-2024-01-03
$161.0 Million
Image
Keros Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about CatalystPharmaceuticals-2024-01-04
$150.0 Million
Image
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Praxis-20234-01-11
$172.4 Million
Image
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Expro-2023-01-12
$151.8 Million
Image
Expro Group
Follow-On Offering
Passive Bookrunner
Read more
about SuperMicro-2023-11-30
$632.9 Million
Image
Super Micro Computer, Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
Read more
about Merit Medical Systems, Inc.
$747.5 Million
Image
Merit Medical Systems, Inc.
Convertible Offering
Active Bookrunner
Read more
about CCC-2023-11-08
$733.6 Million
Image
CCC Intelligent Solutions Holdings Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 21
Next page
››
Subscribe to Equity Capital Markets